|
|
Legal status
Patent in force
| (51) | INT.CL. | G01N 33/68 | (2006.01) |
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 3635408 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18728389.0 |
| Date of filing the European patent application | 2018-06-01 | |
| (97) | Date of publication of the European application | 2020-04-15 |
| (45) | Date of publication and mention of the grant of the patent | 2025-04-30 |
| (46) | Date of publication of the claims translation | 2025-08-11 |
| (86) | Number | PCT/EP2018/064468 |
| Date | 2018-06-01 |
| (87) | Number | WO 2018/224405 |
| Date | 2018-12-13 |
| (30) | Number | Date | Country code |
| PCT/EP2017/064140 | 2017-06-09 | WO |
| (72) |
SAHIN, Ugur , DE
|
| (73) |
BioNTech SE ,
An der Goldgrube 12, 55131 Mainz,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Ligai specifinių aminorūgščių modifikacijų tinkamumo imunoterapijai numatymo būdai |
| METHODS FOR PREDICTING THE USEFULNESS OF DISEASE SPECIFIC AMINO ACID MODIFICATIONS FOR IMMUNOTHERAPY |
| Payment date | Validity (years) | Amount | |
| 2025-05-20 | 8 | 185.00 EUR |
| 2026-06-01 |